Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
复制标题
Cdh1 介导的薯蓣皂苷降解 Skp2 重新编程有氧糖酵解并抑制结直肠癌细胞生长
DOI:
10.1016/j.ebiom.2019.11.031
复制
发表时间:
2019-12
期刊:
影响因子:
11.1
通讯作者:
Liu H
中科院分区:
文献类型:
--
作者:
Zhou L;Yu X;Li M;Gong G;Liu W;Li T;Zuo H;Li W;Gao F;Liu H
BackgroundThe F-box protein S-phase kinase-associated protein 2 (Skp2) is overexpressed and correlated with poor prognosis in human malignancies, including colorectal cancer (CRC).MethodsA natural product library was used for natural compound screening through glycolysis analysis. The expression of Skp2 in CRCs and the inhibitory effect of dioscin on glycolysis were examined through methods of immunoblot, immunofluorescence, immunohistochemical staining, anchorage-dependent and -independent growth assays, EdU incorporation assay, ubiquitination analysis, co-immunoprecipitation assay, CRISPR-Cas9-based gene knockout, and xenograft experiment.FindingsWe demonstrated that Skp2 was highly expressed in CRC tissues and cell lines. Knockout of Skp2 inhibited HK2 and glycolysis and decreased CRC cell growthin vitroandin vivo. We screened 88 commercially available natural products and found that dioscin, a natural steroid saponin derived from several plants, significantly inhibited glycolysis in CRC cells. Dioscin decreased the protein level of Skp2 by shortening the half-life of Skp2. Further study showed that dioscin attenuated Skp2 phosphorylation on S72 and promoted the interaction between Skp2 and Cdh1, which eventually enhanced Skp2 lysine 48 (K48)-linked polyubiquitination and degradation. Depletion of Cdh1 impaired dioscin-induced Skp2 reduction, rescued HK2 expression, and glycolysis in CRC cells. Finally, dioscin delayed thein vivotumor growth, promoted Skp2 ubiquitination, and inhibited Skp2 expression in a mouse xenograft model.InterpretationThis study suggests that in addition to pharmacological inactivation of Skp2, enhancement of ubiquitination-dependent Skp2 turnover is a promising approach for cancer treatment.
登录
查看更多内容
影响因子:
4.6
作者:
Wang C;Huo X;Wang L;Meng Q;Liu Z;Liu Q;Sun H;Sun P;Peng J;Liu K
通讯作者:
Liu K
DOI:
--
发表时间:
2002-11
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Guang Yang;G. Ayala;A. D. De Marzo;W. Tian;A. Frolov;T. Wheeler;T. Thompson;J. Harper
通讯作者:
Guang Yang;G. Ayala;A. D. De Marzo;W. Tian;A. Frolov;T. Wheeler;T. Thompson;J. Harper
影响因子:
11.2
作者:
S. Uddin;Maqbool Ahmed;P. Bavi;raafat El-Sayed;N. Al‐Sanea;Alaa S. Abduljabbar;L. Ashari;S. Alhomoud;F. Al-Dayel;A. Hussain;K. Al-Kuraya
通讯作者:
S. Uddin;Maqbool Ahmed;P. Bavi;raafat El-Sayed;N. Al‐Sanea;Alaa S. Abduljabbar;L. Ashari;S. Alhomoud;F. Al-Dayel;A. Hussain;K. Al-Kuraya
影响因子:
--
作者:
Liu H;Li W;Yu X;Gao F;Duan Z;Ma X;Tan S;Yuan Y;Liu L;Wang J;Zhou X;Yang Y
通讯作者:
Yang Y
影响因子:
3.4
作者:
Adekola K;Rosen ST;Shanmugam M
通讯作者:
Shanmugam M